Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Novartis
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center